High eye pressure with a healthy optic nerve is called ocular hypertension. It is not glaucoma, but it raises your risk, so a full assessment must precede any decision to treat. Ocular Hypertension is a condition in which the pressure inside the eye, the intraocular pressure (IOP), is consistently elevated above the statistically normal range of 10 to 21 mmHg, without any detectable damage to the optic nerve or loss of peripheral vision at the time of diagnosis.
Dr Shibal Bhartiya, fellowship trained glaucoma specialist in Gurgaon, explains what is Ocular Hypertension or High Pressure, and what happens after you are diagnosed with OHT. High eye pressure in adults usually has no symptoms. Also, it is important to understand ocular hypertension vs glaucoma, its treatment, and how corneal thickness affects your glaucoma risk. Read on.
It is one of the most common findings in a routine eye check. Yet for many patients, it arrives as a confusing, vaguely alarming discovery: “Your eye pressure is high.” What does that actually mean? Does it mean glaucoma? Does it mean you need treatment immediately? Will you lose your vision? What are the symptoms of high eye pressure?
The answers are nuanced, and that nuance matters enormously.
Ocular hypertension is not the same as glaucoma.
It is, however, the single most important modifiable risk factor for developing glaucoma, the leading cause of irreversible blindness worldwide. Understanding the difference, and responding appropriately, is what this guide is about.
Clinical insight: Ocular hypertension is a “watch and act” diagnosis. It demands expert assessment– not panic, and not neglect. The right response depends on your individual risk profile, not on pressure alone.
Please also read Myths About Eye Pressure.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,600+ patient reviews on Google.
How the Eye Regulates Its Own Pressure
Intraocular pressure is a product of the balance between production and drainage. When drainage is impaired, even without a complete blockage, fluid accumulates and pressure builds. In most forms of ocular hypertension and open-angle glaucoma, the drainage angle is open but the trabecular meshwork is not functioning efficiently. The eye is like a sink with a slow drain: water fills at a normal rate, but cannot leave fast enough.
Elevated IOP, sustained over months and years, places mechanical and vascular stress on the optic nerve, the cable that carries visual information from the eye to the brain. Once optic nerve fibres are damaged, the loss is permanent. This is why detecting and managing elevated pressure before damage begins is so critical.
Causes and Risk Factors for Ocular Hypertension of High Eye Pressure
Ocular hypertension does not have a single cause. Several factors can contribute, and some dramatically amplify the risk of converting to glaucoma over time.
Primary (Idiopathic) Ocular Hypertension
In most cases, elevated eye pressure occurs without an identifiable secondary cause. Genetic predisposition, reduced trabecular meshwork efficiency with age, and variations in aqueous production all contribute. This is by far the most common form.
Secondary causes of Ocular Hypertension in Gurgaon are no different than in other places across the globe, these include
Secondary Causes
- Steroid-induced ocular hypertension: Prolonged use of corticosteroid eye drops, oral steroids, nasal sprays, or even skin creams near the eye can raise IOP in susceptible individuals. “Steroid responders” are often unaware of this risk.
- Pseudoexfoliation syndrome: A condition in which abnormal protein material deposits in the trabecular meshwork, impairing drainage. It carries a higher risk of glaucomatous damage for a given pressure level.
- Pigment dispersion syndrome: Pigment granules shed from the iris clog the trabecular meshwork, raising IOP, more common in young, myopic males.
- Trauma: Blunt injury to the eye (angle recession) can cause chronic pressure elevation years after the original incident.
- Uveitis (ocular inflammation): Inflammatory cells and debris can obstruct drainage.
- Medications: Certain antidepressants, antihistamines, and decongestants can provoke acute or chronic IOP elevation.
Key Risk Factors for Conversion to Glaucoma
| Risk Factor | Why It Matters | Clinical Action |
|---|---|---|
| IOP > 26 mmHg | Linear relationship with optic nerve stress | Earlier treatment usually advised |
| Thin central cornea (< 555 µm) | True IOP is usually underestimated by standard tonometry; also, thin corneas means higher risk of progression | Pachymetry essential; adjust IOP & risk interpretation |
| Vertical cup-to-disc ratio > 0.5 | Suggests less optic nerve reserve | OCT nerve fibre layer baseline mandatory |
| Family history of glaucoma | Genetic susceptibility to optic nerve damage | Lower threshold for intervention |
| Age > 60 | Longer life exposure + reduced repair capacity | Closer monitoring intervals |
| African or Asian ancestry | Higher glaucoma prevalence; may respond differently | Population-specific risk stratification |
| High myopia (> -6D) | Optic nerve structurally more vulnerable | OCT interpretive caution required |
| Diabetes mellitus (conflicting evidence) | Vascular risk compounds mechanical IOP effects | Good blood sugar controlled |
| Pseudoexfoliation | Higher damage risk per unit of IOP | More aggressive target IOP |
Symptoms of High Eye Pressure: Why Most Patients Feel Nothing
Patients often wonder about what are the symptoms of high eye pressure or OHT.
This is perhaps the most important paragraph in this entire article: ocular hypertension is almost always completely silent. You will not feel it. There is no pain, no headache, no blurring, no haloes around lights, nothing to alert you that your eye pressure is elevated and your optic nerve is at risk.
The rare exception is acutely elevated pressure (above 40–50 mmHg), as seen in acute angle-closure glaucoma: a sudden, painful, vision-threatening emergency with redness, severe headache, nausea, and haloes around lights. Chronic ocular hypertension causes none of these symptoms.
The clinical implication is direct: the only way to know your eye pressure is elevated is to have it measured. Routine eye pressure screening, especially for anyone over 40, or with any of the risk factors listed above, is not optional. It is essential preventive care.
How Ocular Hypertension Is Diagnosed: What a Full Assessment Looks Like
A diagnosis of ocular hypertension should never rest on a single IOP reading from a single visit. A thorough evaluation by a glaucoma specialist includes the following:
1. Goldmann Applanation Tonometry (GAT)
The gold standard for IOP measurement. A small probe is placed on the anaesthetised cornea at a slit lamp to directly measure pressure. More accurate than non-contact air-puff tonometry used in screening settings.
2. Central Corneal Thickness (Pachymetry)
Corneal thickness affects your glaucoma risk, and may affect IOP readings. A thin cornea gives falsely low readings; a thick cornea gives falsely high ones. Without pachymetry, you cannot know your true IOP, and you cannot stratify your glaucoma risk accurately. This test is indispensable in any competent ocular hypertension evaluation.
3. Optic Nerve Assessment: Clinical and Imaging
The optic disc is examined through a dilated pupil and photographed. Optical coherence tomography (OCT) of the retinal nerve fibre layer (RNFL) and ganglion cell complex (GCC) establishes a baseline. This is the benchmark against which future scans will be compared to detect any early deterioration — often before it becomes visible on standard clinical examination.
4. Gonioscopy
A specialised lens is used to examine the drainage angle of the eye. This determines whether the angle is open or narrow or closed- a distinction that completely changes management. Open-angle OHT and angle-closure OHT require different treatment strategies entirely.
5. Visual Field Testing
Standard automated perimetry ( Visual Field analysis) maps the full extent of your peripheral vision. In true ocular hypertension, the visual field is normal. Any abnormality suggests early glaucoma rather than pre-glaucomatous OHT.
6. Diurnal IOP Curve
IOP fluctuates throughout the day- often peaking in the early morning. A single reading may miss peak pressure. In selected patients, measurements at multiple time points reveal a fuller picture of actual IOP burden.
Second opinion, when it matters most
If you have been told your eye pressure is high, but have not had pachymetry, gonioscopy, and OCT imaging, visual fields -or if you are unsure whether treatment is necessary, a specialist second opinion is not excess caution.
It is good medicine. Unnecessary treatment carries real costs; delayed treatment of true risk carries irreversible ones.
Why Corneal Thickness (CCT) Matters in High Eye Pressure
Your eye pressure reading depends partly on your cornea. A thick cornea can make your pressure look higher than it is. A thin cornea can hide a high pressure.
The Goldmann Applanation Tonometer (GAT) does not measure the fluid inside your eye directly. It measures the force needed to flatten a small area of your cornea, 3.06 mm wide. The instrument assumes a central corneal thickness of about 520 to 540 microns. Real corneas vary.
- Thick cornea: It resists flattening. The tonometer reads the pressure higher than it truly is. This can cause “false” ocular hypertension.
- Thin cornea: It flattens easily. The tonometer reads the pressure lower than it truly is. A normal reading can hide a higher true pressure.
What the Ocular Hypertension Treatment Study (OHTS) showed
The Ocular Hypertension Treatment Study (OHTS) is one of the most influential glaucoma trials. It taught us two things about corneal thickness.
- Thick corneas are common in people with high readings. Many participants had thicker-than-average corneas. For some of them, the reading overstates the true pressure.
- A thin cornea is an independent risk factor. People with thin corneas had about three times the risk of developing glaucoma, compared with thick corneas at similar pressures.
Why pachymetry is essential
Pachymetry is a quick, painless measurement of your central corneal thickness. Every complete glaucoma evaluation should include it. Without it, we cannot judge your risk accurately.
No reliable formula corrects eye pressure for corneal thickness. Corneal stiffness and elasticity differ from person to person. So I do not use a “subtract a fixed amount per 20 microns” rule.
Instead, I weigh your CCT alongside your optic nerve on OCT, your visual fields, and your drainage angle on gonioscopy.
An example: Two people each read 24 mmHg. The first has a 610 micron cornea, a healthy nerve, and normal fields. This person likely needs careful monitoring, not lifelong eye drops. The second has a 500 micron cornea. At the same reading, this person has a higher risk of glaucoma and needs a closer look.
Read more about how pressure is measured.
Ocular Hypertension vs Glaucoma: Understanding the Difference
Patients frequently confuse ocular hypertension with glaucoma, or assume that one automatically becomes the other.
Here is the precise distinction:
- Ocular hypertension: IOP is elevated (>21 mmHg), but no optic nerve damage and no visual field defect is detectable at the time of examination. The optic nerve is, as yet, intact.
- Glaucoma: There is already structural damage to the optic nerve, typically visible on OCT as thinning of the retinal nerve fibre layer, and/or functional damage, seen as defects on visual field testing. This damage is irreversible.
Ocular hypertension is therefore a pre-glaucoma risk state, not glaucoma itself. The critical goal of management is to intervene (when warranted) before that threshold is crossed.
It is also important to note that glaucoma can occur without elevated IOP. Approximately 30–40% of glaucoma patients in Asian populations have pressure within the statistically normal range: so-called normal-tension glaucoma (NTG). This reinforces why comprehensive optic nerve evaluation, and not pressure measurement alone, is the foundation of glaucoma diagnosis.
Ocular Hypertension vs. Glaucoma: Key Differences at a Glance
| Feature | Ocular Hypertension (OHT) | Glaucoma (OAG / ACG / NTG) |
| Eye Pressure (IOP) | Consistently elevated (>21 mmHg) | Can be high, borderline, or completely normal (Normal Tension Glaucoma) |
| Optic Nerve Head | Healthy & robust; normal neuroretinal rim; no glaucomatous cupping | Damaged / thinning; progressive loss of retinal nerve fibers (RNFL thinning on OCT) |
| Visual Fields | Normal; no blind spots or peripheral vision loss on perimeter tests | Deficits present; progressive peripheral or paracentral scotomas (blind spots) |
| Drainage Angle | Typically open and clear on gonioscopy | Open, anatomically narrow, or mechanically occluded depending on the type |
| Vision Threat | Non-immediate; acts as a modifiable risk factor, not active disease | Irreversible; progressive loss of functional sight if left uncontrolled |
| Treatment Approach | Risk-stratified: active surveillance without drops or selective low-dose therapy | Immediate & lifelong: target IOP reduction via eye drops, SLT laser, or surgery |
Quick Clinical Takeaway
- Ocular Hypertension = High pressure, but the optic cable is structurally sound and vision is fully intact.
- Glaucoma = Active disease characterized by optic nerve damage and vision loss, regardless of what the pressure number reads.
Do You Need Eye Drops If Your Optic Nerve Is Healthy?
The most common, anxiety-inducing question patients ask when diagnosed with ocular hypertension is: “My eye pressure is 24, but my doctor said my optic nerve and visual fields look healthy. Do I really need to start lifelong pressure-lowering drops today?”
The short answer is: Not necessarily, and certainly not automatically.
Having high eye pressure (IOP) is not synonymous with having glaucoma. Glaucoma is defined by progressive optic neuropathy—structural damage to retinal ganglion cell axons and corresponding visual field loss. Elevated IOP is merely the primary modifiable risk factor, not the disease itself.
Starting lifelong medical therapy is a significant commitment. Daily hypotensive eye drops carry real consequences: ocular surface toxicity, chronic dry eyes, hyperpigmentation, conjunctival hyperemia, systemic cardiopulmonary side effects, and daily treatment fatigue. Therefore, initiating treatment must be a calculated clinical decision rather than a reflexive reaction to a single number on a tonometer.
What Clinical Trials Teach Us: The OHTS Risk Model
The landmark Ocular Hypertension Treatment Study (OHTS) demonstrated that while lowering intraocular pressure by 20% reduced the five-year cumulative risk of developing glaucoma from 9.5% to 4.4%, over 90% of untreated ocular hypertension patients did not develop glaucoma during the same five-year follow-up period.
Treating every individual with elevated pressure indiscriminately results in widespread overtreatment. Instead of treating pressure alone, clinical guidelines employ multivariate risk models that calculate your individual 5-year percentage risk of converting to glaucoma based on:
- Baseline IOP level
- Central Corneal Thickness (CCT)
- Vertical Cup-to-Disc Ratio (VCDR) on high-definition OCT
- Pattern Standard Deviation (PSD) on baseline Humphrey visual field testing
- Age and family history of glaucoma
The Decision Matrix: The L.I.F.T.S.™ Clinical Approach
To bring clarity to this grey zone, patient evaluations are structured around the L.I.F.T.S.™ Framework, which evaluates the whole clinical picture rather than isolated test readings:
L.I.F.T.S.™ for ocular hypertension:
- L. Longitudinal Record Integration: I gather every past pressure reading, so we judge the trend and not one number. Also, does a diurnal curve reveal sustained dangerous pressure peaks, or was the high reading a transient spike?
- I. Independent Diagnostic Re-Evaluation: I repeat the assessment with pachymetry, gonioscopy, OCT, and fields, to confirm this is OHT and not early glaucoma.
- F. Functional Rate-of-Progression: Serial visual fields show whether anything is changing.
- T. Target IOP & Lifetime Risk: We set a personal pressure goal, weighed against your age and risk. What is the safe physiological threshold for this specific eye? A patient with thick corneas (>580microns) and healthy neuroretinal rims can safely tolerate a baseline of 24 mmHg, whereas someone with thin corneas (<500 microns) cannot.
- S. Proportional & Sustainable Plan: We choose the lightest plan that protects your nerve. The first question to be answered: Does this patient’s 5-year conversion risk exceed the physical, financial, and ocular-surface burden of daily medications?
The output is Observe, Refine, or Escalate.
Treatment vs. Active Surveillance
Based on this comprehensive risk stratification, patients fall into two distinct pathways:
- Active Vigilant Surveillance (No Drops):If your corneal pachymetry is thick, your OCT scans demonstrate robust neuroretinal rim volume, your gonioscopy confirms wide, healthy angles, and your 5-year conversion risk is low (<5\%), the safest clinical recommendation is often observation without medication. We establish a pristine structural baseline and monitor with periodic non-invasive testing every 6 to 12 months.
- Proactive Intervention: If your recorded pressure is dangerously high (>28 mmHg) regardless of corneal thickness), or if multiple risk factors align—such as thin corneas, an enlarged physiological cup, a strong first-degree family history of glaucoma blindness, or pseudoexfoliative material on the lens—preventive pressure-lowering drops or Selective Laser Trabeculoplasty (SLT) are initiated to protect the optic nerve before irreversible vision loss begins.
The takeaway: A healthy optic nerve is your greatest asset. If your scans show no structural stress, you have the luxury of time to evaluate, verify, and make an evidence-based decision rather than rushing into lifelong medications.
Ocular Hypertension Treatment in Gurgaon: What Are the Options?
Not all ocular hypertension requires immediate treatment.
The decision, and this is a decision that should be made collaboratively between patient and specialist, depends on a careful weighing of risk versus benefit.
Treatments have side effects and costs; untreated high-risk OHT carries the risk of irreversible vision loss. Getting this balance right is what a fellowship-trained glaucoma specialist does.
Option 1: Watchful Monitoring (Observation Without Treatment)
For patients with low-to-moderate OHT and a favourable risk profile, younger age, IOP below 26 mmHg, thick corneas, healthy optic nerve, no family history; observation with regular monitoring every 6–12 months is entirely evidence-based.
The Ocular Hypertension Treatment Study demonstrated that most low-risk OHT patients do not convert to glaucoma even without treatment over 5 years.
Option 2: IOP-Lowering Eye Drops
Topical medications remain the most common first-line intervention when treatment is warranted:
- Prostaglandin analogues (latanoprost, bimatoprost, travoprost, tafluprost) — once-daily, highly effective, generally well-tolerated. First choice in most guidelines.
- Beta-blockers (timolol, betaxolol) — effective but contraindicated in asthma, heart block, and severe chronic obstructive pulmonary disease.
- Alpha-2 agonists (brimonidine) — useful add-on therapy; also has potential neuroprotective effects.
- Carbonic anhydrase inhibitors (dorzolamide, brinzolamide) — reduce aqueous production; commonly used in combination drops.
- Rho-kinase inhibitors (netarsudil) — newer class with a unique mechanism; growing evidence base.
Option 3: Selective Laser Trabeculoplasty (SLT)
SLT is a safe, highly effective outpatient laser procedure that stimulates the trabecular meshwork to drain more efficiently, reducing IOP by 20–30% in most patients. It is repeatable, has no systemic side effects, and is increasingly used as a first-line alternative to drops — particularly relevant for patients who struggle with drop compliance or who wish to avoid long-term medication.
The LiGHT trial demonstrated that SLT as primary treatment for ocular hypertension and open-angle glaucoma, was at least as good as drops for quality of life. Almost 70% eyes stayed drop-free at the end of six years.
Option 4: Minimally Invasive Glaucoma Surgery (MIGS)
For patients who need more sustained or greater pressure reduction, or who are having cataract surgery simultaneously, minimally invasive glaucoma surgery (MIGS) offers effective options with a superior safety profile compared to traditional glaucoma surgery. Procedures such as iStent inject, OMNI, and goniotomy enhance trabecular outflow with minimal operative risk. However, this is rarely required, or offered in patients who do not have a cataract.
What Is a “Target IOP”?
Treatment is not simply about getting the pressure below 21 mmHg. A target IOP is a personalised pressure goal, defined by the glaucoma specialist, below which optic nerve damage is unlikely to progress for that individual patient.
Target IOP is lower for higher-risk patients and for those who already show early damage. It typically requires periodic reassessment as the clinical picture evolves.
Not Sure Whether Your Eye Pressure Needs Treatment?
In case your diagnosis is not clear, in case you have not understood your risk of glaucoma, or just want to discuss your treatment options- they are all valid reasons to see a structured glaucoma second opinion for Ocular Hypertension in Gurgaon.
- See a doctor urgently: sudden severe eye pain with a red eye, halos, sudden blurred vision, headache with nausea or vomiting.
- See a doctor: pressure above 21 on more than one visit, no pachymetry, gonioscopy or OCT yet, a family history of glaucoma, or unsure whether to treat.
Patients often seek a second opinion when:
• Diagnosis is not clear, or Target IOP is not discussed
• Multiple glaucoma medications are being prescribed; or Laser treatment has been suggested
• Eye pressure remains uncontrolled
• Surgery is being discussed
At my clinic in Gurgaon structured glaucoma evaluation helps determine the best long-term strategy for protecting vision.
Book an Appointment:
📍 Gurgaon 📞 +91 88826 38735 | 🌐 Contact Us | Second Opinion Form for teleconsults
Frequently Asked Questions: Ocular Hypertension and High Eye Pressure
What are the symptoms of ocular hypertension in adults?
Ocular hypertension in adults almost always has no symptoms at all. You will not feel pain, pressure, or any visual change. The only exception is acutely very high pressure, above 40 to 50 mmHg, which causes sudden eye pain, redness, headache, nausea, and haloes around lights. This is an emergency. Chronic high eye pressure symptoms simply do not exist in most patients. The only way to know your eye pressure is elevated is to have it measured.
What is the difference between ocular hypertension and glaucoma?
Ocular hypertension means your eye pressure is above 21 mmHg but your optic nerve is intact and your visual field is normal. Glaucoma means structural damage to the optic nerve has already occurred, visible on OCT as thinning of the nerve fibre layer, and that damage is irreversible. Ocular hypertension is a pre-glaucoma risk state, not glaucoma itself. The goal of management is to prevent that threshold from being crossed.
Does high eye pressure always lead to glaucoma?
No. Many people with raised eye pressure never develop glaucoma. The Ocular Hypertension Treatment Study showed that most low-risk patients do not convert to glaucoma even without treatment over five years. What determines your individual risk is a combination of factors, pressure level, corneal thickness, optic nerve appearance, family history, and age. Your glaucoma specialist uses these to decide whether you need treatment or careful monitoring.
What is the treatment for ocular hypertension?
Ocular hypertension treatment depends entirely on your individual risk profile. Options include watchful monitoring with regular review every 6 to 12 months, IOP-lowering eye drops such as prostaglandin analogues or beta-blockers, selective laser trabeculoplasty (SLT), which reduces pressure by 20 to 30% without medication, and in selected cases, minimally invasive glaucoma surgery. Not everyone with raised eye pressure needs immediate treatment. The decision must be made collaboratively with a specialist.
What is a glaucoma suspect?
A glaucoma suspect is someone who has one or more features that raise the risk of glaucoma such as elevated eye pressure, a suspicious optic disc appearance, a borderline visual field, or a strong family history, but who does not yet meet the criteria for a confirmed glaucoma diagnosis. Glaucoma suspects need regular, structured monitoring with OCT, visual fields, and optic nerve assessment to detect any early conversion.
How does corneal thickness affect glaucoma risk?
Corneal thickness glaucoma risk works in two ways. First, a thin cornea causes standard tonometry to underestimate true eye pressure, meaning your actual pressure may be higher than the reading suggests. Second, thin corneas are independently associated with a higher risk of glaucoma progression, regardless of the pressure reading. Pachymetry, the painless measurement of corneal thickness, is essential in any complete ocular hypertension assessment. Without it, risk cannot be accurately stratified.
When should I see a glaucoma specialist in Gurgaon for high eye pressure?
You should see a glaucoma specialist in Gurgaon if your eye pressure has been found to be above 21 mmHg on more than one occasion, if you have been diagnosed with ocular hypertension but have not had pachymetry, gonioscopy, and OCT imaging, if you are unsure whether treatment is necessary, or if you have a family history of glaucoma and have not had a full baseline assessment. A specialist evaluation goes well beyond a pressure check, it gives you a complete, documented risk profile and a clear management plan.
How often should ocular hypertension be monitored?
Monitoring frequency depends on your risk level. Low-risk patients with mildly elevated pressure and no other risk factors are typically reviewed every 12 months. Higher-risk patients: with pressures above 26 mmHg, thin corneas, suspicious optic discs, or family history, need more frequent review, often every 4 to 6 months. Each review should include IOP measurement, optic nerve assessment, and serial OCT comparison.
This page is a part of the Glaucoma Hub. you may want to read about Glaucoma Progression, , and Risk Stratification in Glaucoma. Other articles of interest could be Advanced Glaucoma Care in Gurgaon, What Good Glaucoma Care Actually Optimises For, What Happens If Glaucoma Is Left Untreated?, More Glaucoma Eye Drops is Not Better Glaucoma Care, 5 Mistakes Patients Make in Glaucoma Care and Do You Really Need Treatment for Glaucoma?
About the Author
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.
Dr Bhartiya has published peer-reviewed research onglaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes. She is also a committed patient advocate and mainstream medical columnist, translating complex ophthalmic evidence into actionable public health insights across leading national platforms including NDTV and OnlyMyHealth
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery). Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
1600+ Five Star Patient Reviews Google Business Profile
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation
Read her research on PubMed | Google Scholar | ResearchGate | ORCID | Github | Wikidata
📋Upload your reports for a structured review.| 🌐 Contact Us| 📞 +91 88826 38735
⭐ Helped by this article? Leave a Google review — it helps other patients find reliable eye care.
Last Reviewed: October 2026